Carlsmed, Inc. (CARL) Stock Statistics & Valuation Metrics

Carlsmed, Inc. has a market cap or net worth of $304.74M. The enterprise value is $236.37M.

Carlsmed, Inc. has 26,731,993 shares outstanding. The number of shares has decreased by -2.65% in one year.

Carlsmed, Inc.’s return on equity (ROE) is -0.31 and return on invested capital (ROIC) is -26.22%.

The current PE Ratio of Carlsmed, Inc. is ―. Carlsmed, Inc.’s PEG ratio is -0.14.

In the last 12 months, Carlsmed, Inc. had revenue of 50.51M and earned -30.22M in profits. Earnings per share was -2.12.

In the last 12 months, operating cash flow was -28.98M and capital expenditures -642.00K, giving a free cash flow of -29.62M billion.

Carlsmed, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Carlsmed, Inc. upcoming earnings date is Apr 30, 2026, After Close (Confirmed).

Carlsmed, Inc. as a current ratio of 8.87, with Debt / Equity ratio of 17.61%

In the past 12 months, Carlsmed, Inc. has paid 0.00 in taxes.

Carlsmed, Inc. EV to EBITDA ratio is -3.76, with an EV/FCF ratio of -3.62.

Carlsmed, Inc. has $109.79M in cash and marketable securities with $17.41M in debt, giving a net cash position of $92.38M billion.

Gross margin is 75.31%, with operating margin of -60.53%, and net profit margin of -59.82%.

The average price target for Carlsmed, Inc. is $19.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy